Mesalamine intolerance mimics symptoms of active inflammatory bowel disease.
Iofel
Elizaveta
E
Division of Pediatric Gastroenterology and Nutrition, North Shore-Long Island Jewish Health System, New York University School of Medicine, Manhasset, New York, USA. EIOFEL@lij.edu
Chawla
Anupama
A
Daum
Fredric
F
Markowitz
James
J
D015746:Abdominal Pain / Q000209:etiology; D000293:Adolescent; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D003967:Diarrhea / Q000209:etiology; D005260:Female; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D008297:Male; D019804:Mesalamine / Q000009:adverse effects*; D012460:Sulfasalazine / Q000009:adverse effects
D000894:Anti-Inflammatory Agents, Non-Steroidal; D012460:Sulfasalazine; D019804:Mesalamine